References
1. Mekonnen A, Redley B, Manias E. Medication-related harm in older adults: underdiagnosed. MJA Insight+ Issue 22/13 June 2022.
2. Lim R, Ellett LMK, Semple S, et al. The extent of medication-related hospital admissions in Australia: A review from 1988 to 2021. Drug Saf. 2022;45(3):249-257.
3. Page AT, Falster MO, Litchfield M, et al. Polypharmacy among older Australians, 2006-2017: a population-based study. Med J Aust.2019;211(2):71-75.
4. Pardo-Cabello AJ, Manzano-Gamero V, Zamora-Pasadas M, et al. Potentially inappropriate prescribing according to STOPP-2 criteria among patients discharged from Internal Medicine: prevalence, involved drugs and economic cost. Arch Gerontol Geriatr. 2018;74:150-154.
5. Spinewine A, Schmader KE, Barber N, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet (London, England). 2007;370(9582):173-184.
6. O’Mahony D, O’Sullivan D, Byrne S, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2.Age Ageing. 2014;44(2):213-218.
7. Mekonnen AB, Redley B, de Courten B, et al. Potentially inappropriate prescribing and its associations with health-related and system-related outcomes in hospitalised older adults: A systematic review and meta-analysis. Br J Clin Pharmacol. 2021;87(11):4150-4172.
8. Manias E, Kabir MZ, Maier AB. Inappropriate medications and physical function: a systematic review. Ther Adv Drug Saf. 2021;12:20420986211030371.
9. Kaufmann CP, Tremp R, Hersberger KE, et al. Inappropriate prescribing: a systematic overview of published assessment tools.Eur J Clin Pharmacol. 2014;70(1):1-11.
10. Eshetie TC, Roberts G, Nguyen TA, et al. Potentially inappropriate medication use and related hospital admissions in aged care residents: the impact of dementia. Br J Clin Pharmacol. 2020 ;86(12):2414-2423.
11. Manias E, Kusljic S, Lam DL. Use of the Screening Tool of Older Persons’ Prescriptions ( STOPP) and the Screening Tool to Alert doctors to the Right Treatment ( START) in hospitalised older people.Australas J Ageing. 2015;34(4):252-258.
12. Manias E, Maier A, Krishnamurthy G. Inappropriate medication use in hospitalised oldest old patients across transitions of care. Aging Clin Exp Res. 2019;31(11):1661-1673.
13. Ní Chróinín D, Neto HM, Xiao D, et al. Potentially inappropriate medications ( PIMs) in older hospital in-patients: Prevalence, contribution to hospital admission and documentation of rationale for continuation. Australa J Ageing. 2016;35(4):262-265.
14. Poudel A, Peel NM, Nissen L, et al. Potentially inappropriate prescribing in older patients discharged from acute care hospitals to residential aged care facilities. Ann Pharmacother . 2014;48(11):1425-1433.
15. van der Stelt CAK, Vermeulen Windsant-van den Tweel AMA, Egberts ACG, et al. The Association between potentially inappropriate prescribing and medication-related hospital admissions in older patients: A nested case control study. Drug Saf.2016;39(1):79-87.
16. Counter D, Millar JW, McLay JS. Hospital readmissions, mortality and potentially inappropriate prescribing: a retrospective study of older adults discharged from hospital. Br J Clin Pharmacol.2018;84(8):1757-1763.
17. Bo M, Quaranta V, Fonte G, et al. Prevalence, predictors and clinical impact of potentially inappropriate prescriptions in hospital-discharged older patients: A prospective study. Geriatr Gerontol Int. 2018;18(4):561-568.
18. De Vincentis A, Gallo P, Finamore P, et al. Potentially inappropriate medications, drug–drug interactions, and anticholinergic burden in elderly hospitalized patients: does an association exist with post-discharge health outcomes? Drugs Aging. 2020;37(8):585-593.
19. Fabbietti P, Ruggiero C, Sganga F, et al. Effects of hyperpolypharmacy and potentially inappropriate medications (PIMs) on functional decline in older patients discharged from acute care hospitals. Arch Gerontol Geriatr. 2018;77:158-162.
20. Bachmann M, Kool J, Oesch P, Weber M, Bachmann S. Association of potentially inappropriate medications with outcomes of inpatient geriatric rehabilitation : A prospective cohort study. Zeitschrift fur Gerontologie und Geriatrie. 2018;51(7):813-820.
21. Chan CH, Maddison C, Reijnierse EM, Lim WK, Maier AB. The association of comorbidity measures and mortality in geriatric rehabilitation inpatients by cancer status: RESORT. Support Care Cancer. 2021;29(8):4513-4519.
22. Ramsey KA, Rojer AGM, van Garderen E, et al. The association of changes in physical performance during geriatric inpatient rehabilitation with short-term hospital readmission, institutionalization, and mortality: RESORT. J Am Med Dir Assoc.2022 ;23(11):1883.e1-1883.e8.
23. Charlson M, Szatrowski TP, Peterson J, et al. Validation of a combined comorbidity index. J Clin Epidemiol.1994;47(11):1245-1251.
24. Miller MD, Paradis CF, Houck PR, et al. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res.1992;41(3):237-248.
25. Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173(5):489-495.
26. Folstein MF, Folstein SE, McHugh PR. ”Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-198.
27. Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695-699.
28. Storey JE, Rowland JT, Basic D, et al. The Rowland Universal Dementia Assessment Scale (RUDAS): a multicultural cognitive assessment scale. Int Psychogeriatr. 2004;16(1):13-31.
29. Katz S, Ford AB, Moskowitz RW, et al. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA. 1963;185:914-919.
30. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist.1969;9(3):179-186.
31. Komagamine J, Yabuki T, Kobayashi M. Association between potentially inappropriate medications at discharge and unplanned readmissions among hospitalised elderly patients at a single centre in Japan: a prospective observational study. BMJ Open. 2019;9(11):e032574.
32. Chang WT, Kowalski SR, Sorich W, et al. Medication regimen complexity and prevalence of potentially inappropriate medicines in older patients after hospitalisation. Int J Clin Pharm.2017;39(4):867-873.
33. Gutiérrez-Valencia M, Alonso-Renedo J, González-Glaría B, et al. Impact of hospitalization in an acute geriatric unit on polypharmacy and potentially inappropriate prescriptions: A retrospective study.Geriatr Gerontol Int. 2017;17(12):2354-2360.
34. Mekonnen A, Redley B, Crawford K, et al. Associations between hyper-polypharmacy and potentially inappropriate prescribing with clinical and functional outcomes in older adults. Expert Opin Drug Saf. 2022;21(7):985-994.
35. Basnet S, Zhang M, Lesser M, et al. Thirty-day hospital readmission rate amongst older adults correlates with an increased number of medications, but not with Beers medications. Geriatr Gerontol Int. 2018;18(10):1513-1518.
36. Fabbietti P, Di Stefano G, Moresi R, et al. Impact of potentially inappropriate medications and polypharmacy on 3-month readmission among older patients discharged from acute care hospital: a prospective study.Aging Clin Exp Res. 2018;30(8):977-984.
37. Weir DL, Lee TC, McDonald EG, et al. Both new and chronic potentially inappropriate medications continued at hospital discharge are associated with increased risk of adverse events. J Am Geriatr Soc. 2020 Jun;68(6):1184-1192.
38. Anderson K, Stowasser D, Freeman C, et al. Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis. BMJ Open. 2014;4(12):e006544.
39. Tobiano G, Chaboyer W, Teasdale T, et al. Older patient and family discharge medication communication: A mixed-methods study. J Eval Clin Pract. 2021;27(4):898-906.